0001209191-17-007757.txt : 20170203 0001209191-17-007757.hdr.sgml : 20170203 20170203173615 ACCESSION NUMBER: 0001209191-17-007757 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170201 FILED AS OF DATE: 20170203 DATE AS OF CHANGE: 20170203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYNOSURE INC CENTRAL INDEX KEY: 0000885306 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043125110 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 CARLISLE ROAD CITY: WESTFORD STATE: MA ZIP: 01886 BUSINESS PHONE: (978) 256-4200 MAIL ADDRESS: STREET 1: 5 CARLISLE ROAD CITY: WESTFORD STATE: MA ZIP: 01886 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davin Michael R CENTRAL INDEX KEY: 0001345975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51623 FILM NUMBER: 17573296 MAIL ADDRESS: STREET 1: C/O CYNOSURE, INC. STREET 2: 5 CARLISLE ROAD CITY: WESTFORD STATE: MA ZIP: 01886 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-01 0 0000885306 CYNOSURE INC CYNO 0001345975 Davin Michael R C/O CYNOSURE, INC. 5 CARLISLE ROAD WESTFORD MA 01886 1 1 0 0 Chairman, President and CEO Class A Common Stock 2017-02-01 4 A 0 10118 0.00 A 29235 D Class A Common Stock 2017-02-03 4 F 0 5111 50.0998 D 24124 D On February 1, 2017, 10,118 shares that were acquired by the reporting person pursuant to the award of the performance-based stock units vested and were paid to the reporting person. On February 3, 2017, 5,111 of these 10,118 shares were withheld and sold in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to pay the resulting tax liability. The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $50.03 to $51.03 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Christopher J. Geberth, Attorney-in-Fact 2017-02-03